Table III.
Analysis of endpoints reached during the study time.
| Endpoints Reached in Follow-up | (n=80) |
|---|---|
| Total with Neurologic Symptoms | 7 (8.8%) |
|
| |
| Neurologic Symptoms Referable to Occlusion | 6 (7.5%) |
| •Amurosis Fugax | 1 (1.3%) |
| •TIA | 2 (2.5%) |
| •CVA | 3 (3.8%) |
|
| |
| Neurologic Symptoms Referable to Contralateral Carotid | 1 (1.3%) |
| •Amurosis Fugax | 0 |
| •TIA | 0 |
| •CVA | 1 (1.3%) |
|
| |
| Contralateral Revascularization | 15 (18.8%) |
| Average Time to Revascularization | 463 Days |
| Death | 19 (24%) |
TIA, Transient Ischemic Attack; CVA, Stroke.